Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
2
×
azacitidine
beta-thalassemia
boston
boston blog main
boston top stories
clinical study
dacogen
data
deals
decitabine
disease
dna
enzyme
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
gag
gene editing
genome editing
hunter syndrome
ids
insulated genomic domains
kaleido biosciences
mahesh karande
mps ii
mucopolysaccharidosis ii
new york blog main
new york top stories
omega therapeutics
panobinostat
richard young
robert gould
What
morning
2
×
therapeutics
aims
approach
based
benefit
biotech
called
debuts
developing
drugs
editing
epigenetic
epigenetics
field
flagship’s
gene
going
humans
isn't
landmark
little
medicine
medicines
nasdaq
new
omega
phase
reported
reports
research
results
sangamo
startup
step
study
touting
trial
u.s
Language
unset
Current search:
morning
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
